Meghana Bomma, Donovan Lott, Sean Forbes, Renata Shih, John-Anthony Coppola, Jeffrey W Christle, Tina Duong, Joseph Russo, Aditi Pant, Carmen Leon-Astudillo, Julie Berthy, Christina Cousins, Manuela Corti, Barry Byrne, James May, W Xue, Tanja Taivassalo
{"title":"心肺运动试验作为一种综合方法来探索杜氏肌营养不良症的生理局限性。","authors":"Meghana Bomma, Donovan Lott, Sean Forbes, Renata Shih, John-Anthony Coppola, Jeffrey W Christle, Tina Duong, Joseph Russo, Aditi Pant, Carmen Leon-Astudillo, Julie Berthy, Christina Cousins, Manuela Corti, Barry Byrne, James May, W Xue, Tanja Taivassalo","doi":"10.1177/22143602251319170","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Cardiopulmonary exercise testing (CPET) is the gold-standard for quantification of peak oxygen uptake (VO<sub>2</sub>) and cardiorespiratory and muscle responses to exercise. Its application to Duchenne muscular dystrophy (DMD) has been scarce due to the notion that muscle weakness inherent to disease restricts the cardiorespiratory system from reaching maximal capacity.</p><p><strong>Objective: </strong>To investigate the utility of CPET in DMD by 1) establishing whether patients can perform maximal-effort exercise for valid VO<sub>2</sub> peak assessment; 2) quantifying VO<sub>2</sub> peak repeatability; 3) characterizing muscle and cardiorespiratory responses; 4) comparing VO<sub>2</sub> peak to 6-min walk distance (6MWD).</p><p><strong>Methods: </strong>Twenty-seven DMD and eight healthy boys (6 years and older) underwent CPET using an incremental work-rate protocol for leg (ambulatory) or arm (non-ambulatory) cycling with measurement of heart rate (HR) and gas-exchange variables from rest to maximal-effort. The oxygen cost of work (ΔVO<sub>2</sub>/Δwork-rate) was calculated, and peak exercise parameters (VO<sub>2</sub>, HR, O<sub>2</sub> pulse, ventilation (VE) and ventilatory threshold (VT)) were considered valid if the respiratory exchange ratio ≥1.01.</p><p><strong>Results: </strong>VO<sub>2</sub> peak was valid (81.5% of patients), repeatable (intraclass correlation coefficient = 0.998) and low in ambulatory and non-ambulatory DMD compared to controls (19.0 ± 6.0; 10.7 ± 2; 35.2 ± 4.5 mL/kg/min respectively). VT was low (30.8 ± 10.7; 19.4 ± 3.0; 61.2 ± 6.9% VO<sub>2</sub> peak) reflecting significant muscle metabolic impairment. Peak HR in ambulatory-DMD (172 ± 14 bpm) was similar to controls (183 ± 8.3 bpm), but O<sub>2</sub> pulse was low (3.4 ± 1.0; 6.5 ± 1.1 mL/beat). Peak VE/VO<sub>2</sub> (ambulatory = 42.1 ± 6.8; non-ambulatory = 42.2 ± 7.8; controls = 34.3 ± 4.6) and ΔVO<sub>2</sub>/Δwork-rate were elevated (ambulatory = 12.4 ± 4.9; non-ambulatory = 19.0 ± 9.7; controls = 10.1 ± 0.8) revealing ventilatory and mechanical inefficiency. Despite strong correlation between VO<sub>2</sub> peak and 6MWD, severity of impairment was discordant.</p><p><strong>Conclusion: </strong>Valid CPET is feasible in DMD, revealing low VO<sub>2</sub> peak due to abnormal muscle metabolic and cardiorespiratory responses during dynamic exercise. CPET reveals cardiorespiratory limitations in DMD boys with unremarkable 6MWD, and should be considered an integrative approach in clinical care and assessment of emerging therapeutics.</p>","PeriodicalId":16536,"journal":{"name":"Journal of neuromuscular diseases","volume":" ","pages":"408-423"},"PeriodicalIF":3.4000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Cardiopulmonary exercise testing as an integrative approach to explore physiological limitations in Duchenne muscular dystrophy.\",\"authors\":\"Meghana Bomma, Donovan Lott, Sean Forbes, Renata Shih, John-Anthony Coppola, Jeffrey W Christle, Tina Duong, Joseph Russo, Aditi Pant, Carmen Leon-Astudillo, Julie Berthy, Christina Cousins, Manuela Corti, Barry Byrne, James May, W Xue, Tanja Taivassalo\",\"doi\":\"10.1177/22143602251319170\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Cardiopulmonary exercise testing (CPET) is the gold-standard for quantification of peak oxygen uptake (VO<sub>2</sub>) and cardiorespiratory and muscle responses to exercise. Its application to Duchenne muscular dystrophy (DMD) has been scarce due to the notion that muscle weakness inherent to disease restricts the cardiorespiratory system from reaching maximal capacity.</p><p><strong>Objective: </strong>To investigate the utility of CPET in DMD by 1) establishing whether patients can perform maximal-effort exercise for valid VO<sub>2</sub> peak assessment; 2) quantifying VO<sub>2</sub> peak repeatability; 3) characterizing muscle and cardiorespiratory responses; 4) comparing VO<sub>2</sub> peak to 6-min walk distance (6MWD).</p><p><strong>Methods: </strong>Twenty-seven DMD and eight healthy boys (6 years and older) underwent CPET using an incremental work-rate protocol for leg (ambulatory) or arm (non-ambulatory) cycling with measurement of heart rate (HR) and gas-exchange variables from rest to maximal-effort. The oxygen cost of work (ΔVO<sub>2</sub>/Δwork-rate) was calculated, and peak exercise parameters (VO<sub>2</sub>, HR, O<sub>2</sub> pulse, ventilation (VE) and ventilatory threshold (VT)) were considered valid if the respiratory exchange ratio ≥1.01.</p><p><strong>Results: </strong>VO<sub>2</sub> peak was valid (81.5% of patients), repeatable (intraclass correlation coefficient = 0.998) and low in ambulatory and non-ambulatory DMD compared to controls (19.0 ± 6.0; 10.7 ± 2; 35.2 ± 4.5 mL/kg/min respectively). VT was low (30.8 ± 10.7; 19.4 ± 3.0; 61.2 ± 6.9% VO<sub>2</sub> peak) reflecting significant muscle metabolic impairment. Peak HR in ambulatory-DMD (172 ± 14 bpm) was similar to controls (183 ± 8.3 bpm), but O<sub>2</sub> pulse was low (3.4 ± 1.0; 6.5 ± 1.1 mL/beat). Peak VE/VO<sub>2</sub> (ambulatory = 42.1 ± 6.8; non-ambulatory = 42.2 ± 7.8; controls = 34.3 ± 4.6) and ΔVO<sub>2</sub>/Δwork-rate were elevated (ambulatory = 12.4 ± 4.9; non-ambulatory = 19.0 ± 9.7; controls = 10.1 ± 0.8) revealing ventilatory and mechanical inefficiency. Despite strong correlation between VO<sub>2</sub> peak and 6MWD, severity of impairment was discordant.</p><p><strong>Conclusion: </strong>Valid CPET is feasible in DMD, revealing low VO<sub>2</sub> peak due to abnormal muscle metabolic and cardiorespiratory responses during dynamic exercise. CPET reveals cardiorespiratory limitations in DMD boys with unremarkable 6MWD, and should be considered an integrative approach in clinical care and assessment of emerging therapeutics.</p>\",\"PeriodicalId\":16536,\"journal\":{\"name\":\"Journal of neuromuscular diseases\",\"volume\":\" \",\"pages\":\"408-423\"},\"PeriodicalIF\":3.4000,\"publicationDate\":\"2025-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of neuromuscular diseases\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1177/22143602251319170\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/3/4 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of neuromuscular diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/22143602251319170","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/4 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
Cardiopulmonary exercise testing as an integrative approach to explore physiological limitations in Duchenne muscular dystrophy.
Background: Cardiopulmonary exercise testing (CPET) is the gold-standard for quantification of peak oxygen uptake (VO2) and cardiorespiratory and muscle responses to exercise. Its application to Duchenne muscular dystrophy (DMD) has been scarce due to the notion that muscle weakness inherent to disease restricts the cardiorespiratory system from reaching maximal capacity.
Objective: To investigate the utility of CPET in DMD by 1) establishing whether patients can perform maximal-effort exercise for valid VO2 peak assessment; 2) quantifying VO2 peak repeatability; 3) characterizing muscle and cardiorespiratory responses; 4) comparing VO2 peak to 6-min walk distance (6MWD).
Methods: Twenty-seven DMD and eight healthy boys (6 years and older) underwent CPET using an incremental work-rate protocol for leg (ambulatory) or arm (non-ambulatory) cycling with measurement of heart rate (HR) and gas-exchange variables from rest to maximal-effort. The oxygen cost of work (ΔVO2/Δwork-rate) was calculated, and peak exercise parameters (VO2, HR, O2 pulse, ventilation (VE) and ventilatory threshold (VT)) were considered valid if the respiratory exchange ratio ≥1.01.
Results: VO2 peak was valid (81.5% of patients), repeatable (intraclass correlation coefficient = 0.998) and low in ambulatory and non-ambulatory DMD compared to controls (19.0 ± 6.0; 10.7 ± 2; 35.2 ± 4.5 mL/kg/min respectively). VT was low (30.8 ± 10.7; 19.4 ± 3.0; 61.2 ± 6.9% VO2 peak) reflecting significant muscle metabolic impairment. Peak HR in ambulatory-DMD (172 ± 14 bpm) was similar to controls (183 ± 8.3 bpm), but O2 pulse was low (3.4 ± 1.0; 6.5 ± 1.1 mL/beat). Peak VE/VO2 (ambulatory = 42.1 ± 6.8; non-ambulatory = 42.2 ± 7.8; controls = 34.3 ± 4.6) and ΔVO2/Δwork-rate were elevated (ambulatory = 12.4 ± 4.9; non-ambulatory = 19.0 ± 9.7; controls = 10.1 ± 0.8) revealing ventilatory and mechanical inefficiency. Despite strong correlation between VO2 peak and 6MWD, severity of impairment was discordant.
Conclusion: Valid CPET is feasible in DMD, revealing low VO2 peak due to abnormal muscle metabolic and cardiorespiratory responses during dynamic exercise. CPET reveals cardiorespiratory limitations in DMD boys with unremarkable 6MWD, and should be considered an integrative approach in clinical care and assessment of emerging therapeutics.
期刊介绍:
The Journal of Neuromuscular Diseases aims to facilitate progress in understanding the molecular genetics/correlates, pathogenesis, pharmacology, diagnosis and treatment of acquired and genetic neuromuscular diseases (including muscular dystrophy, myasthenia gravis, spinal muscular atrophy, neuropathies, myopathies, myotonias and myositis). The journal publishes research reports, reviews, short communications, letters-to-the-editor, and will consider research that has negative findings. The journal is dedicated to providing an open forum for original research in basic science, translational and clinical research that will improve our fundamental understanding and lead to effective treatments of neuromuscular diseases.